| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 9 | |
| #2 | Australia | 6 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Israel | 3 | |
| #5 | WIPO (World Intellectual Property Organization) | 3 | |
| #6 | Canada | 2 | |
| #7 | China | 2 | |
| #8 | EAPO (Eurasian Patent Organization) | 2 | |
| #9 | Republic of Korea | 2 | |
| #10 | Singapore | 2 | |
| #11 | Taiwan | 2 | |
| #12 | Brazil | 1 | |
| #13 | Japan | 1 | |
| #14 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Name | Total Patents |
|---|---|---|
| #1 | Huh Hoyoung | 21 |
| #2 | Satyal Sanjeev | 21 |
| #3 | Jammalamadaka Vasu | 11 |
| #4 | Savage Scott | 9 |
| #5 | Roberts Brian | 9 |
| #6 | Tipton Kimberly Ann | 9 |
| #7 | Wang Xueyan | 8 |
| #8 | Defert Olivier | 6 |
| #9 | Boland Sandro | 6 |
| #10 | Leysen Dirk | 6 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021041264A1 | Use of a neutrophil elastase inhibitor in lung disease | |
| AU2019257632A1 | Use of neutrophil elastase inhibitors in liver disease | |
| KR20200055065A | Tylanstatin analogs |